Large-scaled human serum sphingolipid profiling by using reversed-phase liquid chromatography coupled with dynamic multiple reaction monitoring of mass spectrometry: Method development and application in hepatocellular carcinoma

•Using tert-butyl methyl ether with mild alkaline hydrolysis for sphingolipid extraction.•UHPLC-dynamic multiple reaction monitoring method for serum sphingolipid profiling.•84 serum endogenous sphingolipids can be detected in a single LC run within 10min. Sphingolipids are a family of bioactive mol...

Full description

Saved in:
Bibliographic Details
Published inJournal of Chromatography A Vol. 1320; pp. 103 - 110
Main Authors Li, Jia, Hu, Chunxiu, Zhao, Xinjie, Dai, Weidong, Chen, Shili, Lu, Xin, Xu, Guowang
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 13.12.2013
Elsevier
Subjects
MRM
Sph
Cer
SM
ESI
Online AccessGet full text

Cover

Loading…
Abstract •Using tert-butyl methyl ether with mild alkaline hydrolysis for sphingolipid extraction.•UHPLC-dynamic multiple reaction monitoring method for serum sphingolipid profiling.•84 serum endogenous sphingolipids can be detected in a single LC run within 10min. Sphingolipids are a family of bioactive molecules with high structural diversity and complexity. They not only serve as integral components of cellular membrane, but also play pivotal roles in signaling and other cellular events. It is desirable for the development of sensitive, robust and structural-specific analytical approaches enabling rapid determination of as many sphingolipid species as possible. Herein we present an analytical method for large-scaled profiling of sphigolipids in human serum, which consisted of an improved extraction protocol using tert-butyl methyl ether combined with mild alkaline hydrolysis, and an ultra high performance reversed-phase liquid chromatography-dynamic multiple reaction monitoring-mass spectrometric (RPLC-dynamic MRM-MS) method. In total 84 endogenous sphingolipid species covering six subcategories (i.e. free sphingoid base, dihydroceramide, ceramide, hexosylceramide, lactosylceramide, and sphingomyelin), were separated and quantified in a single run within 10min. A broad linear range over 2.5–4 orders of magnitude (r2>0.99), a limit of detection of 0.01–0.17pmol/mL, and a limit of quantitation of 0.02–0.42pmol/mL were obtained for each subcategory. Average recovery of each subcategory was within 85.6–95.6%. Median values of coefficient of variation (CV) of all detected 84 sphingolipids were 3.9% and 6.8% for intraday and interday precision, respectively. This method was exemplarily applied in a study regarding dysregulated sphingolipid homeostasis in hepatocellular carcinoma. The establishment of this method provides a useful tool for serum-based high throughput screening of sphingolipid biomarkers and mechanism investigation of sphingolipid metabolic regulation in human disease.
AbstractList •Using tert-butyl methyl ether with mild alkaline hydrolysis for sphingolipid extraction.•UHPLC-dynamic multiple reaction monitoring method for serum sphingolipid profiling.•84 serum endogenous sphingolipids can be detected in a single LC run within 10min. Sphingolipids are a family of bioactive molecules with high structural diversity and complexity. They not only serve as integral components of cellular membrane, but also play pivotal roles in signaling and other cellular events. It is desirable for the development of sensitive, robust and structural-specific analytical approaches enabling rapid determination of as many sphingolipid species as possible. Herein we present an analytical method for large-scaled profiling of sphigolipids in human serum, which consisted of an improved extraction protocol using tert-butyl methyl ether combined with mild alkaline hydrolysis, and an ultra high performance reversed-phase liquid chromatography-dynamic multiple reaction monitoring-mass spectrometric (RPLC-dynamic MRM-MS) method. In total 84 endogenous sphingolipid species covering six subcategories (i.e. free sphingoid base, dihydroceramide, ceramide, hexosylceramide, lactosylceramide, and sphingomyelin), were separated and quantified in a single run within 10min. A broad linear range over 2.5–4 orders of magnitude (r2>0.99), a limit of detection of 0.01–0.17pmol/mL, and a limit of quantitation of 0.02–0.42pmol/mL were obtained for each subcategory. Average recovery of each subcategory was within 85.6–95.6%. Median values of coefficient of variation (CV) of all detected 84 sphingolipids were 3.9% and 6.8% for intraday and interday precision, respectively. This method was exemplarily applied in a study regarding dysregulated sphingolipid homeostasis in hepatocellular carcinoma. The establishment of this method provides a useful tool for serum-based high throughput screening of sphingolipid biomarkers and mechanism investigation of sphingolipid metabolic regulation in human disease.
Sphingolipids are a family of bioactive molecules with high structural diversity and complexity. They not only serve as integral components of cellular membrane, but also play pivotal roles in signaling and other cellular events. It is desirable for the development of sensitive, robust and structural-specific analytical approaches enabling rapid determination of as many sphingolipid species as possible. Herein we present an analytical method for large-scaled profiling of sphigolipids in human serum, which consisted of an improved extraction protocol using tert-butyl methyl ether combined with mild alkaline hydrolysis, and an ultra high performance reversed-phase liquid chromatography-dynamic multiple reaction monitoring-mass spectrometric (RPLC-dynamic MRM-MS) method. In total 84 endogenous sphingolipid species covering six subcategories (i.e. free sphingoid base, dihydroceramide, ceramide, hexosylceramide, lactosylceramide, and sphingomyelin), were separated and quantified in a single run within 10min. A broad linear range over 2.5–4 orders of magnitude (r²>0.99), a limit of detection of 0.01–0.17pmol/mL, and a limit of quantitation of 0.02–0.42pmol/mL were obtained for each subcategory. Average recovery of each subcategory was within 85.6–95.6%. Median values of coefficient of variation (CV) of all detected 84 sphingolipids were 3.9% and 6.8% for intraday and interday precision, respectively. This method was exemplarily applied in a study regarding dysregulated sphingolipid homeostasis in hepatocellular carcinoma. The establishment of this method provides a useful tool for serum-based high throughput screening of sphingolipid biomarkers and mechanism investigation of sphingolipid metabolic regulation in human disease.
Sphingolipids are a family of bioactive molecules with high structural diversity and complexity. They not only serve as integral components of cellular membrane, but also play pivotal roles in signaling and other cellular events. It is desirable for the development of sensitive, robust and structural-specific analytical approaches enabling rapid determination of as many sphingolipid species as possible. Herein we present an analytical method for large-scaled profiling of sphigolipids in human serum, which consisted of an improved extraction protocol using tert-butyl methyl ether combined with mild alkaline hydrolysis, and an ultra high performance reversed-phase liquid chromatography-dynamic multiple reaction monitoring-mass spectrometric (RPLC-dynamic MRM-MS) method. In total 84 endogenous sphingolipid species covering six subcategories (i.e. free sphingoid base, dihydroceramide, ceramide, hexosylceramide, lactosylceramide, and sphingomyelin), were separated and quantified in a single run within 10min. A broad linear range over 2.5-4 orders of magnitude (r(2)>0.99), a limit of detection of 0.01-0.17pmol/mL, and a limit of quantitation of 0.02-0.42pmol/mL were obtained for each subcategory. Average recovery of each subcategory was within 85.6-95.6%. Median values of coefficient of variation (CV) of all detected 84 sphingolipids were 3.9% and 6.8% for intraday and interday precision, respectively. This method was exemplarily applied in a study regarding dysregulated sphingolipid homeostasis in hepatocellular carcinoma. The establishment of this method provides a useful tool for serum-based high throughput screening of sphingolipid biomarkers and mechanism investigation of sphingolipid metabolic regulation in human disease.
Sphingolipids are a family of bioactive molecules with high structural diversity and complexity. They not only serve as integral components of cellular membrane, but also play pivotal roles in signaling and other cellular events. It is desirable for the development of sensitive, robust and structural-specific analytical approaches enabling rapid determination of as many sphingolipid species as possible. Herein we present an analytical method for large-scaled profiling of sphigolipids in human serum, which consisted of an improved extraction protocol using tert-butyl methyl ether combined with mild alkaline hydrolysis, and an ultra high performance reversed-phase liquid chromatography-dynamic multiple reaction monitoring-mass spectrometric (RPLC-dynamic MRM-MS) method. In total 84 endogenous sphingolipid species covering six subcategories (i.e. free sphingoid base, dihydroceramide, ceramide, hexosylceramide, lactosylceramide, and sphingomyelin), were separated and quantified in a single run within 10 min. A broad linear range over 2.5-4 orders of magnitude (r2 > 0.99), a limit of detection of 0.01-0.17 pmol/mL, and a limit of quantitation of 0.02-0.42 pmol/mL were obtained for each subcategory. Average recovery of each subcategory was within 85.6-95.6%. Median values of coefficient of variation (CV) of all detected 84 sphingolipids were 3.9% and 6.8% for intraday and interday precision, respectively. This method was exemplarily applied in a study regarding dysregulated sphingolipid homeostasis in hepatocellular carcinoma. The establishment of this method provides a useful tool for serum-based high throughput screening of sphingolipid biomarkers and mechanism investigation of sphingolipid metabolic regulation in human disease.
Author Dai, Weidong
Li, Jia
Zhao, Xinjie
Hu, Chunxiu
Lu, Xin
Chen, Shili
Xu, Guowang
Author_xml – sequence: 1
  givenname: Jia
  surname: Li
  fullname: Li, Jia
– sequence: 2
  givenname: Chunxiu
  surname: Hu
  fullname: Hu, Chunxiu
– sequence: 3
  givenname: Xinjie
  surname: Zhao
  fullname: Zhao, Xinjie
– sequence: 4
  givenname: Weidong
  surname: Dai
  fullname: Dai, Weidong
– sequence: 5
  givenname: Shili
  surname: Chen
  fullname: Chen, Shili
– sequence: 6
  givenname: Xin
  surname: Lu
  fullname: Lu, Xin
– sequence: 7
  givenname: Guowang
  surname: Xu
  fullname: Xu, Guowang
  email: xugw@dicp.ac.cn
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27975654$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/24210299$$D View this record in MEDLINE/PubMed
BookMark eNqNksuO1DAQRSM0iHnAHyDkDRKbNLbjvGaBNBrxkhqxgXXk2OWOW47tsZ1B_b98CM50AxILYBWndO6t0q26LM6ss1AUzwneEEya1_uNmIKb-YZiUuXSBjfsUXFBurYqq7btzooLjCkp-6atzovLGPcYkxa39ElxThklmPb9RfF9y8MOyii4AYmmZeYWRQjLjKKftN05o72WyAentMn_aDygJa6PAPcQIsjSTzwCMvpuyeBxpuR2gfvpgIRb_Gr8TacJyYPlsxZoXkzSuZwtuEjaWTQ7q5MLq61TaOYx5vYgUvaCFA7X6BOkyUkkc0_j_Aw2IW4l4t4bLfiDh7ZoAp9bCzBmMTwgwYPQNo_ztHisuInw7PS9Kr6-e_vl9kO5_fz-4-3NthSs7lLZdLIHyWtJFZVcdUKwrpZNT8exHhWthCI53boaSSeUANV0WcFaEA1mqm-huipeHX1zXHcLxDTMOq7jcAtuiQNpesb6irX9f6BVjWnNGprRFyd0GWeQgw965uEw_FxiBl6eAL7uUQVuhY6_ubZv66ZmmWNHTgQXYwD1CyF4WG9q2A_H_Q3rTa3VfFNZdv2HTOj0kHkKXJt_id8cxZBzv9cQhig0WAFSh7zgQTr9d4Mfkn7yOg
CODEN JOCRAM
CitedBy_id crossref_primary_10_1007_s00280_018_3655_z
crossref_primary_10_1021_acs_jproteome_8b00270
crossref_primary_10_1152_ajpgi_00153_2014
crossref_primary_10_1007_s41664_017_0028_2
crossref_primary_10_1039_C5RA09429A
crossref_primary_10_1016_j_ejca_2016_10_011
crossref_primary_10_1038_s41564_023_01561_1
crossref_primary_10_3390_ijms23094477
crossref_primary_10_1021_ac5009964
crossref_primary_10_1016_j_chroma_2016_07_008
crossref_primary_10_1158_1055_9965_EPI_21_0687
crossref_primary_10_1016_j_aca_2020_09_060
crossref_primary_10_1007_s00216_016_9775_6
crossref_primary_10_1021_acs_analchem_8b01331
crossref_primary_10_1039_C7AY01922J
crossref_primary_10_1021_acs_analchem_0c04756
crossref_primary_10_3390_biom12050709
crossref_primary_10_1016_j_chroma_2015_01_013
crossref_primary_10_1016_j_jalz_2017_01_008
crossref_primary_10_1016_j_talanta_2021_123006
crossref_primary_10_1016_j_aca_2023_342115
crossref_primary_10_1002_bmc_4094
crossref_primary_10_1007_s00216_021_03853_z
crossref_primary_10_18632_oncotarget_23494
crossref_primary_10_1021_acs_jproteome_5b00841
crossref_primary_10_1016_j_bbalip_2014_04_008
crossref_primary_10_1021_acs_jafc_8b02706
crossref_primary_10_3390_molecules23061324
crossref_primary_10_1016_j_jchromb_2021_122684
crossref_primary_10_1016_j_jchromb_2019_03_008
crossref_primary_10_1016_j_aca_2019_02_021
crossref_primary_10_1016_j_jchromb_2020_122289
crossref_primary_10_1371_journal_pone_0131569
Cites_doi 10.4161/cbt.11.2.14624
10.1016/j.ymeth.2005.01.009
10.1016/j.chroma.2013.04.016
10.1002/rcm.1373
10.1016/j.chroma.2013.05.019
10.1016/j.jchromb.2009.07.008
10.1210/er.2007-0025
10.1194/jlr.R800073-JLR200
10.1194/jlr.D000430
10.1194/jlr.D008532
10.1021/pr070183p
10.1194/jlr.D800051-JLR200
10.1194/jlr.E400004-JLR200
10.1021/ac202646v
10.1016/j.ab.2012.01.027
10.1194/jlr.R003996
10.1016/j.chemphyslip.2011.04.013
10.2174/187152012800228643
10.1007/s11745-011-3633-2
10.1074/jbc.R000005200
10.1021/cr2002917
10.1021/pr800373m
10.2217/fon.10.116
10.1194/jlr.D005322
10.1016/j.ab.2005.01.058
10.1007/s10555-011-9304-1
10.1007/s12272-009-2219-5
10.1007/s00018-007-7076-0
10.1038/nrm2329
10.1016/j.ab.2007.08.019
10.1016/j.bbalip.2011.05.011
10.1373/clinchem.2006.079012
10.1139/o59-099
10.1194/jlr.D700041-JLR200
10.1016/j.jchromb.2006.06.025
10.1016/j.ymeth.2006.05.004
10.1016/j.bbalip.2010.11.003
10.1016/j.jchromb.2013.03.019
10.1016/j.ab.2010.02.023
10.1038/nrc1411
10.1006/abio.2001.5108
ContentType Journal Article
Copyright 2013 Elsevier B.V.
2015 INIST-CNRS
Copyright © 2013 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2013 Elsevier B.V.
– notice: 2015 INIST-CNRS
– notice: Copyright © 2013 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QH
7UA
C1K
F1W
H97
L.G
7S9
L.6
DOI 10.1016/j.chroma.2013.10.064
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Aqualine
Water Resources Abstracts
Environmental Sciences and Pollution Management
ASFA: Aquatic Sciences and Fisheries Abstracts
Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality
Aquatic Science & Fisheries Abstracts (ASFA) Professional
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Aquatic Science & Fisheries Abstracts (ASFA) Professional
Aqualine
Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality
ASFA: Aquatic Sciences and Fisheries Abstracts
Water Resources Abstracts
Environmental Sciences and Pollution Management
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList
AGRICOLA
MEDLINE
Aquatic Science & Fisheries Abstracts (ASFA) Professional
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1873-3778
EndPage 110
ExternalDocumentID 24210299
27975654
10_1016_j_chroma_2013_10_064
S002196731301683X
Genre Validation Studies
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
-~X
.~1
0R~
1B1
1RT
1~.
1~5
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JN
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AARLI
AAXUO
ABFNM
ABFRF
ABJNI
ABMAC
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACRLP
ADBBV
ADECG
ADEZE
AEBSH
AEFWE
AEKER
AENEX
AFKWA
AFTJW
AFZHZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJSZI
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AXJTR
BKOJK
BLXMC
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FLBIZ
FNPLU
FYGXN
G-Q
GBLVA
IH2
IHE
J1W
KOM
M36
M41
MO0
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
Q38
RIG
ROL
RPZ
SCC
SCH
SDF
SDG
SDP
SES
SPC
SPCBC
SSK
SSZ
T5K
WH7
XPP
YK3
ZMT
~02
~G-
~KM
.GJ
29K
AAHBH
AATTM
AAXKI
AAYJJ
AAYWO
AAYXX
ABDPE
ACNNM
ACVFH
ADCNI
AEIPS
AEUPX
AFJKZ
AFPUW
AFXIZ
AGCQF
AGRNS
AI.
AIGII
AIIUN
AJQLL
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
ASPBG
AVWKF
AZFZN
BNPGV
CITATION
D-I
FEDTE
FGOYB
HMU
HVGLF
HZ~
H~9
OHT
SCB
SEW
SSH
UQL
VH1
WUQ
ZGI
ZKB
ZXP
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QH
7UA
C1K
F1W
H97
L.G
7S9
L.6
ID FETCH-LOGICAL-c458t-68d9eda5d2f2daf8cc485d692bb5bf23cf118753b18cfcef6868d47ec604f97e3
IEDL.DBID .~1
ISSN 0021-9673
IngestDate Fri Jul 11 11:03:27 EDT 2025
Fri Jul 11 16:07:00 EDT 2025
Thu Jan 02 22:11:40 EST 2025
Wed Apr 02 07:35:46 EDT 2025
Tue Jul 01 00:46:47 EDT 2025
Thu Apr 24 23:02:29 EDT 2025
Fri Feb 23 02:33:23 EST 2024
IsPeerReviewed true
IsScholarly true
Keywords Tert-butyl methyl ether
Sphingolipid profiling
Multiple reaction monitoring
MRM
Lipidomics
Sph
APCI
dHCer
MTBE
Cer
RPLC
HexCer
LacCer
Serum
SM
ESI
Liquid chromatography–mass spectrometry
NPLC
HILIC
Ultra performance liquid chromatography
Biological fluid
Tandem mass spectrometry
Chemical analysis
Biological marker
Lipids
Hepatic disease
Hepatocellular carcinoma
Solvent extraction
Electrospray
Blood
Sample preparation
Quantitative analysis
Human
Validation
Healthy subject
Liquid liquid extraction
Coupled method
Multiple reaction monitoring mode
Liquid chromatography-mass spectrometry
Sphingolipid
Patient
Malignant tumor
Reversed phase chromatography
Digestive diseases
Blood serum
Chemometrics
Cancer
Principal component analysis
electrospray ionization
ceramide
hydrophilic interaction liquid chromatography
reversed phase liquid chromatography
normal phase liquid chromatography
hexosylceramide
dihydroceramide
lactosylceramide
free sphingoid base
atmospheric-pressure chemical ionization
sphingomyelin
Language English
License CC BY 4.0
Copyright © 2013 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c458t-68d9eda5d2f2daf8cc485d692bb5bf23cf118753b18cfcef6868d47ec604f97e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 24210299
PQID 1635025462
PQPubID 23462
PageCount 8
ParticipantIDs proquest_miscellaneous_1694493479
proquest_miscellaneous_1635025462
pubmed_primary_24210299
pascalfrancis_primary_27975654
crossref_primary_10_1016_j_chroma_2013_10_064
crossref_citationtrail_10_1016_j_chroma_2013_10_064
elsevier_sciencedirect_doi_10_1016_j_chroma_2013_10_064
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-12-13
PublicationDateYYYYMMDD 2013-12-13
PublicationDate_xml – month: 12
  year: 2013
  text: 2013-12-13
  day: 13
PublicationDecade 2010
PublicationPlace Amsterdam
PublicationPlace_xml – name: Amsterdam
– name: Netherlands
PublicationTitle Journal of Chromatography A
PublicationTitleAlternate J Chromatogr A
PublicationYear 2013
Publisher Elsevier B.V
Elsevier
Publisher_xml – name: Elsevier B.V
– name: Elsevier
References Matyash, Liebisch, Kurzchalia, Shevchenko, Schwudke (bib0130) 2008; 49
Kolter (bib0040) 2011; 164
Lee, Choi, Choi, Ji, Yoo, Lee, Hong, Yun, Yoo (bib0065) 2009; 32
Jiang, Cheng, Yang, Gross, Han (bib0160) 2007; 371
Furuya, Shimizu, Kawamori (bib0190) 2011; 30
Ponnusamy, Meyers-Needham, Senkal, Saddoughi, Sentelle, Selvam, Salas, Ogretmen (bib0195) 2010; 6
Bui, Leohr, Kuo (bib0110) 2012; 423
Farwanah, Kolter, Sandhoff (bib0185) 2011; 1811
He, Chen, Gatt, Schuchman (bib0055) 2001; 293
Scherer, Boettcher, Schmitz, Liebisch (bib0155) 2011; 1811
Liang, Wu, Sun, Wang, Hou, Yang, Jiang, Liu, Guo (bib0175) 2013; 1294
Pettus, Kroesen, Szulc, Bielawska, Bielawski, Hannun, Busman (bib0145) 2004; 18
Fahy, Subramaniam, Brown, Glass, Merrill, Murphy, Raetz, Russell, Seyama, Shaw, Shimizu, Spener, van Meer, VanNieuwenhze, White, Witztum, Dennis (bib0005) 2005; 46
Hannun, Obeid (bib0025) 2008; 9
Farwanah, Wirtz, Kolter, Raith, Neubert, Sandhoff (bib0090) 2009; 877
Delgado, Fabrias, Bedia, Casas, Abad (bib0205) 2012; 12
Groener, Poorthuis, Kuiper, Helmond, Hollak, Aerts (bib0070) 2007; 53
Hu, van Dommelen, van der Heijden, Spijksma, Reijmers, Wang, Slee, Lu, Xu, van der Greef, Hankemeier (bib0135) 2008; 7
Shaner, Allegood, Park, Wang, Kelly, Haynes, Sullards, Merrill (bib0095) 2009; 50
Merrill (bib0030) 2011; 111
Ryland, Fox, Liu, Loughran, Kester (bib0045) 2011; 11
Scherer, Leuthaeuser-Jaschinski, Ecker, Schmitz, Liebisch (bib0105) 2010; 51
He, Dagan, Gatt, Schuchman (bib0060) 2005; 340
Gika, Theodoridis, Wingate, Wilson (bib0140) 2007; 6
Bielawski, Szulc, Hannun, Bielawska (bib0085) 2006; 39
Bligh, Dyer (bib0125) 1959; 37
Yoo, Son, Kim (bib0075) 2006; 843
Yan, Li, Lv, Li, Zhou, Yang (bib0180) 2013; 928
Oskouian, Saba (bib0210) 2010
Merrill, Stokes, Momin, Park, Portz, Kelly, Wang, Sullards, Wang (bib0010) 2009; 50
Ogretmen, Hannun (bib0200) 2004; 4
t’Kindt, Jorge, Dumont, Couturon, David, Sandra, Sandra (bib0165) 2012; 84
Holland, Summers (bib0035) 2008; 29
Kasumov, Huang, Chung, Zhang, McCullough, Kirwan (bib0100) 2010; 401
Merrill, Sullards, Allegood, Kelly, Wang (bib0080) 2005; 36
Masood, Rao, Acharya, Blonder, Veenstra (bib0115) 2012; 47
Chen, Hoene, Li, Li, Zhao, Haring, Schleicher, Weigert, Xu, Lehmann (bib0170) 2013; 1298
Brown, London (bib0015) 2000; 275
Lahiri, Futerman (bib0020) 2007; 64
Xu, Barnes, Sun, Grabowski (bib0050) 2010; 51
Wijesinghe, Allegood, Gentile, Fox, Kester, Chalfant (bib0120) 2010; 51
Hammad, Pierce, Soodavar, Smith, Al Gadban, Rembiesa, Klein, Hannun, Bielawski, Bielawska (bib0150) 2010; 51
Delgado (10.1016/j.chroma.2013.10.064_bib0205) 2012; 12
Ponnusamy (10.1016/j.chroma.2013.10.064_bib0195) 2010; 6
He (10.1016/j.chroma.2013.10.064_bib0060) 2005; 340
Gika (10.1016/j.chroma.2013.10.064_bib0140) 2007; 6
Merrill (10.1016/j.chroma.2013.10.064_bib0080) 2005; 36
Merrill (10.1016/j.chroma.2013.10.064_bib0030) 2011; 111
t’Kindt (10.1016/j.chroma.2013.10.064_bib0165) 2012; 84
Scherer (10.1016/j.chroma.2013.10.064_bib0105) 2010; 51
Brown (10.1016/j.chroma.2013.10.064_bib0015) 2000; 275
Chen (10.1016/j.chroma.2013.10.064_bib0170) 2013; 1298
Bligh (10.1016/j.chroma.2013.10.064_bib0125) 1959; 37
Lee (10.1016/j.chroma.2013.10.064_bib0065) 2009; 32
Ogretmen (10.1016/j.chroma.2013.10.064_bib0200) 2004; 4
Farwanah (10.1016/j.chroma.2013.10.064_bib0090) 2009; 877
Yan (10.1016/j.chroma.2013.10.064_bib0180) 2013; 928
Kolter (10.1016/j.chroma.2013.10.064_bib0040) 2011; 164
He (10.1016/j.chroma.2013.10.064_bib0055) 2001; 293
Bui (10.1016/j.chroma.2013.10.064_bib0110) 2012; 423
Kasumov (10.1016/j.chroma.2013.10.064_bib0100) 2010; 401
Wijesinghe (10.1016/j.chroma.2013.10.064_bib0120) 2010; 51
Pettus (10.1016/j.chroma.2013.10.064_bib0145) 2004; 18
Lahiri (10.1016/j.chroma.2013.10.064_bib0020) 2007; 64
Holland (10.1016/j.chroma.2013.10.064_bib0035) 2008; 29
Hu (10.1016/j.chroma.2013.10.064_bib0135) 2008; 7
Jiang (10.1016/j.chroma.2013.10.064_bib0160) 2007; 371
Oskouian (10.1016/j.chroma.2013.10.064_bib0210) 2010
Furuya (10.1016/j.chroma.2013.10.064_bib0190) 2011; 30
Hannun (10.1016/j.chroma.2013.10.064_bib0025) 2008; 9
Hammad (10.1016/j.chroma.2013.10.064_bib0150) 2010; 51
Yoo (10.1016/j.chroma.2013.10.064_bib0075) 2006; 843
Matyash (10.1016/j.chroma.2013.10.064_bib0130) 2008; 49
Xu (10.1016/j.chroma.2013.10.064_bib0050) 2010; 51
Bielawski (10.1016/j.chroma.2013.10.064_bib0085) 2006; 39
Shaner (10.1016/j.chroma.2013.10.064_bib0095) 2009; 50
Scherer (10.1016/j.chroma.2013.10.064_bib0155) 2011; 1811
Merrill (10.1016/j.chroma.2013.10.064_bib0010) 2009; 50
Farwanah (10.1016/j.chroma.2013.10.064_bib0185) 2011; 1811
Ryland (10.1016/j.chroma.2013.10.064_bib0045) 2011; 11
Liang (10.1016/j.chroma.2013.10.064_bib0175) 2013; 1294
Fahy (10.1016/j.chroma.2013.10.064_bib0005) 2005; 46
Groener (10.1016/j.chroma.2013.10.064_bib0070) 2007; 53
Masood (10.1016/j.chroma.2013.10.064_bib0115) 2012; 47
References_xml – volume: 1811
  start-page: 68
  year: 2011
  ident: bib0155
  publication-title: BBA – Mol. Cell Biol.
– volume: 50
  start-page: S97
  year: 2009
  ident: bib0010
  publication-title: J. Lipid Res.
– volume: 64
  start-page: 2270
  year: 2007
  ident: bib0020
  publication-title: Cell. Mol. Life Sci.
– volume: 1294
  start-page: 58
  year: 2013
  ident: bib0175
  publication-title: J. Chromatogr. A
– volume: 7
  start-page: 4982
  year: 2008
  ident: bib0135
  publication-title: J. Proteome Res.
– volume: 6
  start-page: 3291
  year: 2007
  ident: bib0140
  publication-title: J. Proteome Res.
– volume: 51
  start-page: 3074
  year: 2010
  ident: bib0150
  publication-title: J. Lipid Res.
– volume: 46
  start-page: 839
  year: 2005
  ident: bib0005
  publication-title: J. Lipid Res.
– volume: 4
  start-page: 604
  year: 2004
  ident: bib0200
  publication-title: Nat. Rev. Cancer
– volume: 111
  start-page: 6387
  year: 2011
  ident: bib0030
  publication-title: Chem. Rev.
– volume: 293
  start-page: 204
  year: 2001
  ident: bib0055
  publication-title: Anal. Biochem.
– volume: 1811
  start-page: 854
  year: 2011
  ident: bib0185
  publication-title: BBA – Mol. Cell Biol.
– volume: 275
  start-page: 17221
  year: 2000
  ident: bib0015
  publication-title: J. Biol. Chem.
– volume: 164
  start-page: 590
  year: 2011
  ident: bib0040
  publication-title: Chem. Phys. Lipids
– volume: 18
  start-page: 577
  year: 2004
  ident: bib0145
  publication-title: Rapid Commun. Mass Spectrom.
– volume: 9
  start-page: 139
  year: 2008
  ident: bib0025
  publication-title: Nat. Rev. Mol. Cell Biol.
– volume: 50
  start-page: 1692
  year: 2009
  ident: bib0095
  publication-title: J. Lipid Res.
– volume: 39
  start-page: 82
  year: 2006
  ident: bib0085
  publication-title: Methods
– volume: 6
  start-page: 1603
  year: 2010
  ident: bib0195
  publication-title: Future Oncol.
– volume: 11
  start-page: 138
  year: 2011
  ident: bib0045
  publication-title: Cancer Biol. Ther.
– volume: 1298
  start-page: 9
  year: 2013
  ident: bib0170
  publication-title: J. Chromatogr. A
– start-page: 185
  year: 2010
  ident: bib0210
  publication-title: Sphingolipids as Signaling and Regulatory Molecules
– volume: 423
  start-page: 187
  year: 2012
  ident: bib0110
  publication-title: Anal. Biochem.
– volume: 51
  start-page: 1643
  year: 2010
  ident: bib0050
  publication-title: J. Lipid Res.
– volume: 843
  start-page: 327
  year: 2006
  ident: bib0075
  publication-title: J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci.
– volume: 47
  start-page: 209
  year: 2012
  ident: bib0115
  publication-title: Lipids
– volume: 928
  start-page: 22
  year: 2013
  ident: bib0180
  publication-title: J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci.
– volume: 84
  start-page: 403
  year: 2012
  ident: bib0165
  publication-title: Anal. Chem.
– volume: 340
  start-page: 113
  year: 2005
  ident: bib0060
  publication-title: Anal. Biochem.
– volume: 51
  start-page: 2001
  year: 2010
  ident: bib0105
  publication-title: J. Lipid Res.
– volume: 32
  start-page: 1795
  year: 2009
  ident: bib0065
  publication-title: Arch. Pharm. Res.
– volume: 51
  start-page: 641
  year: 2010
  ident: bib0120
  publication-title: J. Lipid Res.
– volume: 877
  start-page: 2976
  year: 2009
  ident: bib0090
  publication-title: J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci.
– volume: 49
  start-page: 1137
  year: 2008
  ident: bib0130
  publication-title: J. Lipid Res.
– volume: 29
  start-page: 381
  year: 2008
  ident: bib0035
  publication-title: Endocr. Rev.
– volume: 401
  start-page: 154
  year: 2010
  ident: bib0100
  publication-title: Anal. Biochem.
– volume: 371
  start-page: 135
  year: 2007
  ident: bib0160
  publication-title: Anal. Biochem.
– volume: 53
  start-page: 742
  year: 2007
  ident: bib0070
  publication-title: Clin. Chem.
– volume: 12
  start-page: 285
  year: 2012
  ident: bib0205
  publication-title: Anti-Cancer Agents Med.
– volume: 30
  start-page: 567
  year: 2011
  ident: bib0190
  publication-title: Cancer Metastasis Rev.
– volume: 36
  start-page: 207
  year: 2005
  ident: bib0080
  publication-title: Methods
– volume: 37
  start-page: 911
  year: 1959
  ident: bib0125
  publication-title: Can. J. Biochem. Physiol.
– volume: 11
  start-page: 138
  year: 2011
  ident: 10.1016/j.chroma.2013.10.064_bib0045
  publication-title: Cancer Biol. Ther.
  doi: 10.4161/cbt.11.2.14624
– volume: 36
  start-page: 207
  year: 2005
  ident: 10.1016/j.chroma.2013.10.064_bib0080
  publication-title: Methods
  doi: 10.1016/j.ymeth.2005.01.009
– volume: 1294
  start-page: 58
  year: 2013
  ident: 10.1016/j.chroma.2013.10.064_bib0175
  publication-title: J. Chromatogr. A
  doi: 10.1016/j.chroma.2013.04.016
– volume: 18
  start-page: 577
  year: 2004
  ident: 10.1016/j.chroma.2013.10.064_bib0145
  publication-title: Rapid Commun. Mass Spectrom.
  doi: 10.1002/rcm.1373
– volume: 1298
  start-page: 9
  year: 2013
  ident: 10.1016/j.chroma.2013.10.064_bib0170
  publication-title: J. Chromatogr. A
  doi: 10.1016/j.chroma.2013.05.019
– volume: 877
  start-page: 2976
  year: 2009
  ident: 10.1016/j.chroma.2013.10.064_bib0090
  publication-title: J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci.
  doi: 10.1016/j.jchromb.2009.07.008
– volume: 29
  start-page: 381
  year: 2008
  ident: 10.1016/j.chroma.2013.10.064_bib0035
  publication-title: Endocr. Rev.
  doi: 10.1210/er.2007-0025
– volume: 50
  start-page: S97
  year: 2009
  ident: 10.1016/j.chroma.2013.10.064_bib0010
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.R800073-JLR200
– volume: 51
  start-page: 641
  year: 2010
  ident: 10.1016/j.chroma.2013.10.064_bib0120
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.D000430
– volume: 51
  start-page: 3074
  year: 2010
  ident: 10.1016/j.chroma.2013.10.064_bib0150
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.D008532
– volume: 6
  start-page: 3291
  year: 2007
  ident: 10.1016/j.chroma.2013.10.064_bib0140
  publication-title: J. Proteome Res.
  doi: 10.1021/pr070183p
– volume: 50
  start-page: 1692
  year: 2009
  ident: 10.1016/j.chroma.2013.10.064_bib0095
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.D800051-JLR200
– volume: 46
  start-page: 839
  year: 2005
  ident: 10.1016/j.chroma.2013.10.064_bib0005
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.E400004-JLR200
– volume: 84
  start-page: 403
  year: 2012
  ident: 10.1016/j.chroma.2013.10.064_bib0165
  publication-title: Anal. Chem.
  doi: 10.1021/ac202646v
– volume: 423
  start-page: 187
  year: 2012
  ident: 10.1016/j.chroma.2013.10.064_bib0110
  publication-title: Anal. Biochem.
  doi: 10.1016/j.ab.2012.01.027
– volume: 51
  start-page: 1643
  year: 2010
  ident: 10.1016/j.chroma.2013.10.064_bib0050
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.R003996
– volume: 164
  start-page: 590
  year: 2011
  ident: 10.1016/j.chroma.2013.10.064_bib0040
  publication-title: Chem. Phys. Lipids
  doi: 10.1016/j.chemphyslip.2011.04.013
– volume: 12
  start-page: 285
  year: 2012
  ident: 10.1016/j.chroma.2013.10.064_bib0205
  publication-title: Anti-Cancer Agents Med.
  doi: 10.2174/187152012800228643
– volume: 47
  start-page: 209
  year: 2012
  ident: 10.1016/j.chroma.2013.10.064_bib0115
  publication-title: Lipids
  doi: 10.1007/s11745-011-3633-2
– volume: 275
  start-page: 17221
  year: 2000
  ident: 10.1016/j.chroma.2013.10.064_bib0015
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.R000005200
– volume: 111
  start-page: 6387
  year: 2011
  ident: 10.1016/j.chroma.2013.10.064_bib0030
  publication-title: Chem. Rev.
  doi: 10.1021/cr2002917
– volume: 7
  start-page: 4982
  year: 2008
  ident: 10.1016/j.chroma.2013.10.064_bib0135
  publication-title: J. Proteome Res.
  doi: 10.1021/pr800373m
– volume: 6
  start-page: 1603
  year: 2010
  ident: 10.1016/j.chroma.2013.10.064_bib0195
  publication-title: Future Oncol.
  doi: 10.2217/fon.10.116
– volume: 51
  start-page: 2001
  year: 2010
  ident: 10.1016/j.chroma.2013.10.064_bib0105
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.D005322
– volume: 340
  start-page: 113
  year: 2005
  ident: 10.1016/j.chroma.2013.10.064_bib0060
  publication-title: Anal. Biochem.
  doi: 10.1016/j.ab.2005.01.058
– volume: 30
  start-page: 567
  year: 2011
  ident: 10.1016/j.chroma.2013.10.064_bib0190
  publication-title: Cancer Metastasis Rev.
  doi: 10.1007/s10555-011-9304-1
– volume: 32
  start-page: 1795
  year: 2009
  ident: 10.1016/j.chroma.2013.10.064_bib0065
  publication-title: Arch. Pharm. Res.
  doi: 10.1007/s12272-009-2219-5
– volume: 64
  start-page: 2270
  year: 2007
  ident: 10.1016/j.chroma.2013.10.064_bib0020
  publication-title: Cell. Mol. Life Sci.
  doi: 10.1007/s00018-007-7076-0
– start-page: 185
  year: 2010
  ident: 10.1016/j.chroma.2013.10.064_bib0210
– volume: 9
  start-page: 139
  year: 2008
  ident: 10.1016/j.chroma.2013.10.064_bib0025
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/nrm2329
– volume: 371
  start-page: 135
  year: 2007
  ident: 10.1016/j.chroma.2013.10.064_bib0160
  publication-title: Anal. Biochem.
  doi: 10.1016/j.ab.2007.08.019
– volume: 1811
  start-page: 854
  year: 2011
  ident: 10.1016/j.chroma.2013.10.064_bib0185
  publication-title: BBA – Mol. Cell Biol.
  doi: 10.1016/j.bbalip.2011.05.011
– volume: 53
  start-page: 742
  year: 2007
  ident: 10.1016/j.chroma.2013.10.064_bib0070
  publication-title: Clin. Chem.
  doi: 10.1373/clinchem.2006.079012
– volume: 37
  start-page: 911
  year: 1959
  ident: 10.1016/j.chroma.2013.10.064_bib0125
  publication-title: Can. J. Biochem. Physiol.
  doi: 10.1139/o59-099
– volume: 49
  start-page: 1137
  year: 2008
  ident: 10.1016/j.chroma.2013.10.064_bib0130
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.D700041-JLR200
– volume: 843
  start-page: 327
  year: 2006
  ident: 10.1016/j.chroma.2013.10.064_bib0075
  publication-title: J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci.
  doi: 10.1016/j.jchromb.2006.06.025
– volume: 39
  start-page: 82
  year: 2006
  ident: 10.1016/j.chroma.2013.10.064_bib0085
  publication-title: Methods
  doi: 10.1016/j.ymeth.2006.05.004
– volume: 1811
  start-page: 68
  year: 2011
  ident: 10.1016/j.chroma.2013.10.064_bib0155
  publication-title: BBA – Mol. Cell Biol.
  doi: 10.1016/j.bbalip.2010.11.003
– volume: 928
  start-page: 22
  year: 2013
  ident: 10.1016/j.chroma.2013.10.064_bib0180
  publication-title: J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci.
  doi: 10.1016/j.jchromb.2013.03.019
– volume: 401
  start-page: 154
  year: 2010
  ident: 10.1016/j.chroma.2013.10.064_bib0100
  publication-title: Anal. Biochem.
  doi: 10.1016/j.ab.2010.02.023
– volume: 4
  start-page: 604
  year: 2004
  ident: 10.1016/j.chroma.2013.10.064_bib0200
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1411
– volume: 293
  start-page: 204
  year: 2001
  ident: 10.1016/j.chroma.2013.10.064_bib0055
  publication-title: Anal. Biochem.
  doi: 10.1006/abio.2001.5108
SSID ssj0017072
ssj0029838
Score 2.28728
Snippet •Using tert-butyl methyl ether with mild alkaline hydrolysis for sphingolipid extraction.•UHPLC-dynamic multiple reaction monitoring method for serum...
Sphingolipids are a family of bioactive molecules with high structural diversity and complexity. They not only serve as integral components of cellular...
SourceID proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 103
SubjectTerms alkaline hydrolysis
bioactive properties
Biological and medical sciences
biomarkers
blood serum
Carcinoma, Hepatocellular - blood
cell membranes
ceramides
Chromatography, Reverse-Phase - methods
detection limit
hepatoma
homeostasis
Host-tumor relations. Immunology. Biological markers
human diseases
Humans
Lipidomics
Liquid chromatography–mass spectrometry
Liver Neoplasms - blood
mass spectrometry
Medical sciences
monitoring
Multiple reaction monitoring
Reproducibility of Results
reversed-phase liquid chromatography
screening
Serum
Sphingolipid profiling
Sphingolipids - blood
sphingomyelins
Tandem Mass Spectrometry - methods
Tert-butyl methyl ether
Tumors
Title Large-scaled human serum sphingolipid profiling by using reversed-phase liquid chromatography coupled with dynamic multiple reaction monitoring of mass spectrometry: Method development and application in hepatocellular carcinoma
URI https://dx.doi.org/10.1016/j.chroma.2013.10.064
https://www.ncbi.nlm.nih.gov/pubmed/24210299
https://www.proquest.com/docview/1635025462
https://www.proquest.com/docview/1694493479
Volume 1320
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZWywEkhHhTHtUgcc1ukzh-cFtVrAqlFUKs6C1KbIcGtUno48CFX8sPYSZOuuxhWYlTFcvjuO6X8dT5Zj7G3tjYqUSFPNBGuIBnhQnyKJLBSOVa5aGIsjaLfzYXkwv-YZEsjti4z4UhWmXn-71Pb71113LareZpU5aU44tPm5AxeuFQqHhBGexcEspPfh1oHqEcyUM9qUir2Ltm4iWgaZ9L1xK-zHJTt6WIwviECF-CX7dX3W2yLa5g4aUvro9N2z3q_D671wWXcObn_4Adueohuz3uNd0esd8fifgd0LDOQqvPB4jB_Rq2DR1F1auyKS14IW-8hvwnEDP-G1Clp83W2aBZ4r4Hq_LHHjv6L7Pryl6DqfcNDUyHu2C91j30lEUcwidRwLr1I3SgCHUBawzfoU34pMoJOM23MGtlrcFeEpogqyz89bIdygqWuJPuanrzQFRaMKSKVOF0HrOL83dfxpOg03kIDE_ULhDKamezxEZFZLNCGcNVYoWO8jzJiyg2BWmiJ3EeKlMYVwiFFlw6I0a80NLFT9hxVVfuGYO8sKPIWq3QiksusqQtkTfK4owq27sBi_tfNDVdEXTS4lilPdvte-qXLiUcUCviYMCCg1Xji4Dc0F_2YEmvgDnFfeoGy-EVbB1uF0ktMfbGDq97sKWIHVrjrHL1fptiYJ1QaQMR_auP5lxT8vCAPfVIvbwDp3__Wj__78m_YHfoisg-YfySHe82e_cKQ7ZdPmyfySG7dfZ-OpnT5_Tz1ym2zj_N_gBKXkp5
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nj9MwELWW5bBICPFN-VgGiWt2G8dxbG6oYlWg3dOu1FuU2A4NapPQNgcu_Fp-CDNx0mUPy0ocm3ocxx2Pp86b9xh7byOnYhWKQBvpApEVJsg5T4KxyrXKQ8mzrop_fi6nl-LLIl4csMlQC0Owyj72-5jeRev-ymk_m6dNWVKNL642mUQYhUOposUddlfg8iUZg5Nfe5xHmIyTPaEU1yrysZmACWg7FNN1iC-z3NQdF1EYnRDiS4qbNqv7TbbFKSy89sXNyWm3SZ09ZA_67BI--gd4xA5c9ZgdTQZRtyfs94yQ3wF16yx0An2ATtiuYdvQWVS9KpvSglfyxs-Q_wSCxn8DonrabJ0NmiVufLAqf7TY0D_Mrue9BlO3DXVMp7tgvdg9DJhF7MJXUcC6CyR0ogh1AWvM36Gr-CTqBBzmB5h3utZgrxBNkFUW_nrbDmUFS9xKdzW9eiAsLRiSRapwOE_Z5dmni8k06IUeAiNitQukstrZLLa84DYrlDFCxVZqnudxXvDIFCSKHkd5qExhXCEVWojEGTkWhU5c9IwdVnXlXjDICzvm1mqFViIRMos7jrxxFmVEbe9GLBp-0dT0LOgkxrFKB7jb99RPXUp-QFfRD0Ys2Fs1ngXklvbJ4CzpNW9OcaO6xfL4mm_tb8cTnWDyjQ3eDc6Wou_QHGeVq9ttipl1TNwGkv-rjRZCU_XwiD33nnp1B0F__7V--d-Df8uOphfzWTr7fP71FbtH3xDyJ4xes8PdpnVvMH_b5cfd-vwDWppJWA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Large-scaled+human+serum+sphingolipid+profiling+by+using+reversed-phase+liquid+chromatography+coupled+with+dynamic+multiple+reaction+monitoring+of+mass+spectrometry%3A+Method+development+and+application+in+hepatocellular+carcinoma&rft.au=Li%2C+Jia&rft.au=Hu%2C+Chunxiu&rft.au=Zhao%2C+Xinjie&rft.au=Dai%2C+Weidong&rft.date=2013-12-13&rft.issn=0021-9673&rft.volume=1320+p.103-110&rft.spage=103&rft.epage=110&rft_id=info:doi/10.1016%2Fj.chroma.2013.10.064&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9673&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9673&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9673&client=summon